05369nam 2201405z- 450 991074327570332120230911(CKB)5690000000228551(oapen)doab113905(EXLCZ)99569000000022855120230920c2023uuuu -u- -engurmn|---annantxtrdacontentcrdamediacrrdacarrierBrain Injury and Neurodegeneration: Molecular, Functional, and Translational ApproachMDPI - Multidisciplinary Digital Publishing Institute20231 online resource (428 p.)3-0365-8385-8 With the advancements in the medical and scientific fields, the global community has acquired a comprehensive understanding about brain insults and pathologies. In addition, new findings and discoveries are being made globally every day, which keep our curiosity high and drive a knowledge gain. Any brain insult or pathology is multifactorial, including a cascade of inflammation, necrotic, and apoptotic pathways; can be influenced by genetic or environmental factors; and may lead to chronic neurodegeneration or disabilities. This Special Issue, entitled "Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach", has addressed various important aspects of brain injury and neurodegeneration, such as TBI, cerebral hypoxia, epilepsy, AD, and SARS-CoV-2-mediated brain damage. It received appreciable global response, and published 18 peer-reviewed articles, including 10 research articles and 8 reviews. Briefly, it explores the recent coronavirus infection-mediated cerebral damage; discusses the mechanism of TBI, ischemia, hypoxia, and epilepsy; talks about neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and CONDCA; and, finally, reviews the translational values of phytochemicals in brain pathologies. In conclusion, this Special Issue provides a unique review on brain injury and neurodegeneration, and will be a good tool in enhancing knowledge in terms of brain disease-related pathology, mechanisms, and translational approach.Brain Injury and NeurodegenerationMedicine and NursingbicsscNeurology and clinical neurophysiologybicssc18F-FDG PETAGTPBP1Alzheimer's diseaseamyloid betaanosmiaanti-convulsantsanti-epileptic drugsapoptosisblunt-force TBIbrain injuryCCP1chronic alcoholismcognitive impairmentCONDCACOVID-19drug targetsedemaepigeneticsepileptogenesisexcitotoxicityexomiRNAexosomeextracellular matrixFABP3FABP5FABP7gene regulationGSK-3βHHV-6histone deacetylasehistone deacetylase inhibitorhypoxiahypoxic-ischemic injuriesicariinicaritininflammationischemiaischemic strokeisomiRmechanical stimulationsmicrogliamicroRNAmiddle cerebral artery occlusionmild traumatic brain injurymiRNAmitochondriamoderate traumatic brain injurymPGES-1n/anatural productsneural ischemianeural mitochondrial functionsneural tissue hypoxic injuriesneuraxisneuro-recoveryneurodegenerationneurodegenerative diseasesneuroinflammationneuronsneuroprotectionneurorehabilitationneurotraumaNNA1non-communicable diseaseolfactory dysfunctionorganelle dysfunctionoxidative stressp-TauParkinson's diseasepcdPGE2phytochemicalspost-traumatic seizurespseudo-resistancepurmorphaminereactive oxygen speciesRNAseqSARS-CoV-2seizuressonic hedgehog signalingstretchingSubstantia NigraTBItherapeutic strategiestranscriptional modificationstraumatic brain injurytraumatic brain injury (TBI)treadmill exercisetRNAzebrafishMedicine and NursingNeurology and clinical neurophysiologyBOOK9910743275703321Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach3560553UNINA